Fora Capital, LLC G1 Therapeutics, Inc. Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$13.16 - $22.47 $26,912 - $45,951	-2,045 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $40,020 - $53,824	2,045 New	2,045 $45 Million
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $334,037 - $619,242	-19,001 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$10.99 - $20.4 $176,147 - $326,971	16,028 Added 539.12%	19,001 $341,000
Q3 2020 Nov 13, 2020	BUY	$11.55 - $23.75 $34,338 - $70,608	2,973 New	2,973 $34 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.